Yahoo Finance 2020 Market Study on the Seasonal Influenza Vaccines Industry - COVID-19 has Prompted a Surge in Demand
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Infectious Diseases Disease Analysis: Seasonal Influenza Vaccines" report has been added to ResearchAndMarkets.com's offering.
The seasonal influenza vaccines market in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) is expected to continue to expand over the next 10 years, largely due to the continued uptake of premium-priced vaccines in the elderly subgroup, including quadrivalent forms of Fluzone High-Dose (HD) and Fluad, as well as the launch of the first-in-class adjuvanted nanoparticle vaccine, NanoFlu.
Further to this, an aging population in the US, Japan, five major European markets, and other developed countries will increase the number of patients, where coverage rates are higher. Additionally, the COVID-19 pandemic has prompted an unexpected surge in demand for influenza vaccines due to heightened public awareness of the threat posed by respiratory viruses to the elderly and those with co-morbidities, as well as the potential burden on healthcare services of coinciding COVID-19 and influenza waves.
Key Topics Covered:
Disease Background and Vaccination Guidelines
Vaccine Landscape
Marketed Vaccines
Pipeline Vaccines
Key Regulatory Events
Probability of Success
Clinical Trial Landscape
Market Assessment and Disease Analysis
Vaccine Assessments
Market Dynamics
Future Trends
Consensus Forecasts
Recent Events and Analyst Opinion
Key Upcoming Events
Unmet Needs
For more information about this report visit https://www.researchandmarkets.com/r/uqj6rt
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
